05.03.2012 18:50 Uhr, Quelle: Wallstreet online

ThromboGenics Opens New U.S. Headquarters

LEUVEN, Belgium, March 5, 2012 /PRNewswire/ U.S. Organization Continues to Build Ahead of Ocriplasmin´s Planned Launch ThromboGenics NV , a biopharmaceutical company focused on developing innovative ophthalmic medicines, announces the …

Weiterlesen bei Wallstreet online

Digg del.icio.us Facebook email MySpace Technorati Twitter

JustMac.info © Thomas Lohner - Impressum - Datenschutz